Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 1 |
2016 | 1 |
2017 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Quoted phrase not found in phrase index: "Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1"
Page 1
A clinical and molecular genetic study of a rare dominantly inherited syndrome (MRCS) comprising of microcornea, rod-cone dystrophy, cataract, and posterior staphyloma.
Br J Ophthalmol. 2003 Feb;87(2):197-202. doi: 10.1136/bjo.87.2.197.
Br J Ophthalmol. 2003.
PMID: 12543751
Free PMC article.
Clinical Trial.
AIM: To phenotype and genetically map the disease locus in a family presenting with autosomal dominant microcornea, rod-cone dystrophy, cataract, and posterior staphyloma. METHODS: Six affected and three unaffected members o …
AIM: To phenotype and genetically map the disease locus in a family presenting with autosomal dominant microcornea, rod-con …
Fundus Autofluorescence and SD-OCT Document Rapid Progression in Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC) Associated with a c.256G > A Mutation in BEST1.
Kellner S, Stöhr H, Fiebig B, Weinitz S, Farmand G, Kellner U, Weber BH.
Kellner S, et al.
Ophthalmic Genet. 2016 Jun;37(2):201-8. doi: 10.3109/13816810.2015.1033556. Epub 2016 Jan 15.
Ophthalmic Genet. 2016.
PMID: 26771239
PURPOSE: To report the variability of clinical findings, rapid concentric progression, and successful treatment of macular edema in autosomal dominant vitreoretinochoroidopathy (ADVIRC) associated with a heterozygous c.256G > A missense mutation in the bestrophin …
PURPOSE: To report the variability of clinical findings, rapid concentric progression, and successful treatment of macular edema in a …
Item in Clipboard
The incidence and risk factors for the development of vitreomacular interface abnormality in diabetic macular edema treated with intravitreal injection of anti-VEGF.
Chang CK, Cheng CK, Peng CH.
Chang CK, et al.
Eye (Lond). 2017 May;31(5):762-770. doi: 10.1038/eye.2016.317. Epub 2017 Jan 20.
Eye (Lond). 2017.
PMID: 28106889
Free PMC article.
Poor baseline BCVA was found to be a risk factor for VMIA development (P=0.001, odds ratio=5.299, 95% confidence interval: 1.972 to 14.238). There was no difference between eyes with and without VMIA formation in improving BCVA (P=0.557) and lowering the macular edema (eye …
Poor baseline BCVA was found to be a risk factor for VMIA development (P=0.001, odds ratio=5.299, 95% confidence interval: 1.972 to 1 …
Item in Clipboard
Cite
Cite